06:06 EDT Shuttle Pharmaceuticals files to sell common stock, warrants, no amount given
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHPH:
- Shuttle Pharmaceuticals expands clinical trial site enrollment for Phase 2 trial
- Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
- Shuttle Pharmaceuticals announces issuance of U.S. patent HDAC inhibitors
- Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
- Shuttle Pharmaceuticals gets ODD for IPdR to treat brain tumors